Market Strategy & Commercialization

In the most simplistic terms, every successful company must create a product, make a product and sell a product. In the medical device world, taking a patented and regulatory approved product to market integration requires a deep understanding of every facet of the commercialization pathway and a well-established sales channel.

Our team of experts possesses over a century of medical device commercialization experience and key industry relationships. We intimately understand what a well-defined commercialization roadmap looks like. Most importantly, we know how to skillfully execute the plan and all associated strategic activities, reduce bottlenecks and harmonize work streams to deliver successful and timely exits for our clients.

Engaging Our Network

Medical Device Commercialization Capabilities

Our network is vast and encompasses all stakeholders in the commercialization process. We leverage our relationships with a wide range of highly respected medical device professionals early in our process to evaluate all commercialization opportunities. Their hands-on experience and deep relationships offer critical insights into market viability, sales potential, and surgeon adoption requirements. Engaging these experts early is crucial and accelerates our positioning of a product for success in the market.

About Us

01

Networking Support, Introductions and Relationship Building

02

KOL and Surgeon Advisory Board Creation

03

Inventory and Logistics

04

Fulfillment & Replenishment

05

Independent Distribution Team

06

Surgeon and Sales Training

07

IRB and VAC Approvals

08

Hospital and ASC Contracts

09

Clinical Data Collection

10

Industry Meeting Presence

11

Strategic Marketing

12

Social Media Presence

Current & Exited Clients

Pre-Commercial

Commercial

Exited

IPO

EXITED

EXITED

Chance Leonard

Chance Leonard, Chief Executive Officer

"Simply said, a company must execute three overarching objectives with the highest standard of excellence; it must create a product, make a product and sell a product. Genesis Innovation Group understands this requirement well and begins preparing market entry and commercialization efforts as soon as a product is being designed. We create a tailored, strategic plan outlining the pathway to success through our expertise in targeted growth trajectory, order fulfillment and safety stock, increased market visibility and footprint, important industry relationships, beneficial pricing agreements with ASCs Hospitals, IDNs and GPOs, and clinical training of customers through our highly skilled and independent commercial team."

Contact Us

Reach out to our team if you have a great idea that you think you can serve the medical community.

Connect with Us

Start typing and press enter to search

Scroll to Top

The SupraSpacer™ restores anatomical spacing and natural joint alignment, allowing smooth articulation. It reduces impingement-related discomfort and supports balanced shoulder mechanics.

SupraSpacer™ acts as a supportive spacer within the shoulder joint. When the rotator cuff is torn and unable to support the joint effectively, the humerus slowly shifts upward, which limits function. By re-establishing normal spacing, SupraSpacer™ realigns the joint to its natural position.

Nanochon is an early-stage medical device company developing an innovative implant designed to address one of the most challenging problems in orthopedics: cartilage repair for pre-replacement candidates.

Their focus is on treating focal cartilage lesions (essentially “potholes” in the cartilage surface of joints), a condition that leads to pain, loss of function, and a diminished quality of life.

Currently, patients at this stage face limited options: lifestyle changes and pain management are often no longer effective, and the path forward typically leads toward invasive procedures or joint replacement. Nanochon aims to fill this treatment gap with our Chondrograft™ engineered to provide both immediate mechanical support and long-term repair potential.

Their proprietary technology centers on a fully synthetic, nylon-based composite material that mimics the structure and mechanical properties of natural cartilage. Using advanced 3D printing, we create a highly engineered implant that fits precisely into the damaged area, restoring joint function and serving as a scaffold for tissue repair.

The INTEGRATE®-C Fusion Device is made of a single, continuous piece of hydroxyapatite impregnated polyetheretherketone polymer.

The INTEGRATE®-C Fusion Device is monolithic with porous regions derived directly from the implant body, not a sintered or otherwise additive coating, and extended through the device.

The device is available in a variety of footprints, lordosis and heights to accommodate variations in the individual pathology and anatomy of the patient. The superior and inferior surfaces of the device contain a pattern of teeth to provide for initial stability. Radiopaque markers are placed in the device to aid in determining the location of the implant intra- and post-operatively.

Designed with dense and porous HAPPE® material placed to promote both load bearing and healing.

ProVoyance™ specializes in custom software development platforms for healthcare and digital health, creating breakthrough, integrated tools for medical use.

Using artificial intelligence (AI) and machine learning (ML) technologies, the ProVoyance team transforms medical imaging and patient engagement into actionable tools with a singular mission: to minimize the invasive.

Working together with medical professionals and organizations, they are able to leverage their platform technologies to create custom solutions. 

Around 80% of Americans suffer from back pain, and their journey is filled with frustration, impersonalized care, and poor results.

Back pain comes from over 100 different causes, and a one-size-fits-all approach simply isn’t helping most patients.

MyBackHub integrates leading AI scanning technology, personal health history, and expert guidance to create a care plan that evolves with patient needs.

Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty.

These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.

Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration.

Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Embody is pioneering the next generation of soft tissue regeneration creating a platform of biointegrative solutions to support healing in the most challenging orthopedic soft tissue injuries.

Embody® was acquired by Zimmer Biomet in 2023.

Imascap develops software for preoperative planning of shoulder replacement surgery.

Imascap was Acquired by Wright Medical in December 2017.